However, whether this alteration of epithelial ST2L is a feedback response to the chronic exposure of elevated IL-33 concentrations or an intrinsic epithelial defect characterizing IBD has yet to be determined. The gene discussed is IL1RL1; the disease is inflammatory bowel disease.